Skip to main content
. 2017 Apr 28;8(35):58699–58708. doi: 10.18632/oncotarget.17506

Figure 2. The five-lncRNA related risk score model predicts overall survival of patients with ccRCC in the testing set and the entire set.

Figure 2

(A) Kaplan-Meier estimates plots of the survival of the ccRCC patients using the five-lncRNA signature-related risk score model in the testing set (n=220). (B) Kaplan-Meier estimates plots of the survival of the ccRCC patients using the five-lncRNA signature-related risk score model in the entire set (n=440).